foscarnet has been researched along with Benign Neoplasms, Brain in 3 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Malignant gliomas are the most common malignant brain tumors and are almost always fatal." | 1.28 | Experimental therapy of human glioma by means of a genetically engineered virus mutant. ( Coen, DM; Malick, A; Markert, JM; Martuza, RL; Ruffner, KL, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mordenti, P | 1 |
| Zaffignani, E | 1 |
| Immovilli, P | 1 |
| Nobili, E | 1 |
| Cavanna, L | 1 |
| Inaba, H | 1 |
| Rabah, R | 1 |
| Meert, KL | 1 |
| BhamBhani, K | 1 |
| Martuza, RL | 1 |
| Malick, A | 1 |
| Markert, JM | 1 |
| Ruffner, KL | 1 |
| Coen, DM | 1 |
3 other studies available for foscarnet and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Human herpesvirus 6 encephalitis simulating brain metastases in a patient with advanced small-cell lung cancer.
Topics: Antiviral Agents; Brain Neoplasms; Encephalitis, Viral; Foscarnet; Ganciclovir; Herpesvirus 6, Human | 2013 |
Herpes simplex virus pneumonia in a patient with ependymoma.
Topics: Acyclovir; Antiviral Agents; Brain Neoplasms; Child, Preschool; Drug Therapy, Combination; Ependymom | 2004 |
Experimental therapy of human glioma by means of a genetically engineered virus mutant.
Topics: Animals; Antiviral Agents; Brain Neoplasms; Cells, Cultured; Dose-Response Relationship, Drug; Fosca | 1991 |